This Month in JAAD International: November 2021: COVID-19 and Hair Loss

    Jonathan Kantor
    Studysummary This study observed that among patients with COVID-19 who have hair disorders, telogen effluvium is common, and the presence of trichodynia may lead to earlier presentation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management JAAD International · 2021

    Related research 6

    1. Hair Loss Pharmacy Today · 2021
    2. Hair Loss: Causes and Pathology International Journal of Research in Medical Sciences & Technology · 2021
    3. Diffuse Hair Loss Elsevier eBooks · 2021
    4. Treatment of Female Pattern Hair Loss with Combination Therapy Seminars in Cutaneous Medicine and Surgery · 2018
    5. A Review on Hair Loss and Damage 2016
    6. Viviscal: An Answer for Hair Loss in Women? Pharmacy Today · 2013